Nuklearmedizinische Bildgebungsverfahren für die Kardiologie

Kardiale nuklearmedizinische Bildgebungsverfahren haben sich als wichtige Techniken in Diagnose, Therapie und Prognose von Herz-Kreislauf-Erkrankungen etabliert. Der folgende Artikel bietet eine umfassende Übersicht über die klinische Anwendung dieser Verfahren mit einem Schwerpunkt auf koronare Herzerkrankung, Myokarditis und infektiöse Endokarditis sowie Amyloidose.

Schlüsselwörter

Bildgebung - Kardiologie - Nuklearmedizin - SPECT - PET - Szintigrafie - Kardiomyopathie - entzündliche Herzerkrankungen - infektiöse Endokarditis

• Literatur

• 1 Lindner O, Bauersachs J, Bengel F. et al. [Policy paper nuclear cardiology – update 2018 – Current status of clinical practice]. Nuklearmedizin 2018; 57: 146-152
• 2 Tamaki N, Manabe O. Current status and perspectives of nuclear cardiology. Ann Nucl Med 2024; 38: 20-30
• 3 Arai AE, Schulz-Menger J, Shah DJ. et al. Stress Perfusion Cardiac Magnetic Resonance vs SPECT Imaging for Detection of Coronary Artery Disease. J Am Coll Cardiol 2023; 82: 1828-1838
• 4 Nayfeh M, Ahmed AI, Saad JM. et al. The Role of Cardiac PET in Diagnosis and Prognosis of Ischemic Heart Disease: Optimal Modality Across Different Patient Populations. Curr Atheroscler Rep 2023; 25: 351-357
• 5 Dorbala S, Ando Y, Bokhari S. et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imaging. J Nucl Cardiol 2019; 26: 2065-2123
• 6 Schockling EJ, Farrell MB, Embry-Dierson M. et al. Cardiac Amyloidosis Imaging, Part 2: Quantification and Technical Considerations. J Nucl Med Technol 2023; 51: 90-98
• 7 Slart RHJA, Glaudemans AWJM, Gheysens O. et al. Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM. Eur J Nucl Med Mol Imaging 2021; 48: 1016-1039
• 8 Papathanasiou M, Kessler L, Bengel FM. et al. Regression of Myocardial 99mTc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin Amyloidosis. J Nucl Med 2023; 64: 1083-1086
• 9 Garcia-Pavia P, aus dem Siepen F, Donal E. et al. Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid. N Engl J Med 2023; 389: 239-250
• 10 Gherghe M, Lazar AM, Sterea M-C. et al. Quantitative SPECT/CT Parameters in the Assessment of Transthyretin Cardiac Amyloidosis—A New Dimension of Molecular Imaging. J Cardiovasc Dev Dis 2023; 10: 242
• 11 Slart RHJA, Glaudemans AWJM, Lancellotti P. et al. A joint procedural position statement on imaging in cardiac sarcoidosis: From the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology. Eur Heart J Cardiovasc Imaging 2017; 18: 1073-1089
• 12 Schindler TH, Solnes L. Role of PET/ CT for the Identification of Cardiac Sarcoid Disease. Ann Nucl Cardiol 2015; 1: 79-86
• 13 Mahrholdt H, Sechtem U. Gewebedifferenzierung mittels Kontrast-MRT („late enhancement“). Kardiologe 2008; 2: 215-226
• 14 Greulich S, Gatidis S, Gräni C. et al. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis. JACC Cardiovasc Imaging 2022; 15: 445-456
• 15 Delgado V, Ajmone Marsan N, De Waha S. et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J 2023; 44: 3948-4042
• 16 Rouzet F, Chequer R, Benali K. et al. Respective performance of 18F-FDG PET and radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis. J Nucl Med 2014; 55: 1980-1985
• 17 Ten Hove D, Slart RHJA, Sinha B. et al. 18F-FDG PET/CT in Infective Endocarditis: Indications and Approaches for Standardization. Curr Cardiol Rep 2021; 23: 130
• 18 Krumm P, Greulich S, la Fougère C. et al. Hybrid-PET/MRT bei inflammatorischer Kardiomyopathie. Radiologie 2022; 62: 954-959
• 19 Krumm P, Mangold S, Gatidis S. et al. Clinical use of cardiac PET/MRI: current state-of-the-art and potential future applications. Jpn J Radiol 2018; 36: 313-323
• 20 Lindner O. Deutsche Gesellschaft für Nuklearmedizin e.V. (DGN). S1-Leitlinie Myokard-Perfusions-SPECT(-CT): DGN-Handlungsempfehlung (S1-Leitlinie). 2023 Zugriff am 23. August 2024 unter: https://register.awmf.org/de/leitlinien/detail/031-006
• 21 Abbott BG, Case JA, Dorbala S. et al. Contemporary Cardiac SPECT Imaging-Innovations and Best Practices: An Information Statement from the American Society of Nuclear Cardiology. Circ Cardiovasc Imaging 2018; 11: e000020
• 22 Slomka P, Hung G-U, Germano G, Berman DS. Novel SPECT Technologies and Approaches in Cardiac Imaging. Cardiovasc Innov Appl 2016; 2: 31-46
• 23 Einstein AJ, Blankstein R, Andrews H. et al. Comparison of image quality, myocardial perfusion, and left ventricular function between standard imaging and single-injection ultra-low-dose imaging using a high-efficiency SPECT camera: the MILLISIEVERT study. J Nucl Med 2014; 55: 1430-1437
• 24 Piekarski E, Manrique A, Rouzet F, Le Guludec D. Current Status of Myocardial Perfusion Imaging With New SPECT/CT Cameras. Semin Nucl Med 2020; 50: 219-226
• 25 Small GR, Wells RG, Schindler T. et al. Advances in cardiac SPECT and PET imaging: overcoming the challenges to reduce radiation exposure and improve accuracy. Can J Cardiol 2013; 29: 275-284
• 26 Nayfeh M, Ahmed AI, Saad JM. et al. The Role of Cardiac PET in Diagnosis and Prognosis of Ischemic Heart Disease: Optimal Modality Across Different Patient Populations. Curr Atheroscler Rep 2023; 25: 351-357
• 27 Lindner O, Bauersachs J, Bengel F. et al. Positionspapier Nuklearkardiologie – Update 2018. Kardiologe 2018; 12: 303-311
• 28 Sciagrà R, Lubberink M, Hyafil F. et al. EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging. European journal of nuclear medicine and molecular imaging 2021; 48: 1040-1069
• 29 Dilsizian V, Bacharach SL, Beanlands RS. et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol 2016; 23: 1187-1226
• 30 Bundesamt für Strahlenschutz. Ionisierende Strahlung. Bekanntmachung der aktualisierten diagnostischen Referenzwerte für nuklearmedizinische Untersuchungen vom 15. Juni 2021. Zugriff am 02. September 2024 unter: https://www.bfs.de/SharedDocs/Downloads/BfS/DE/fachinfo/ion/drw-nuklearmedizin.pdf;jsessionid=BCEB79139D9942F08C71DF7CC8288346.internet612?__blob=publicationFile&v=5
• 31 Maddahi J, Bengel F, Czernin J. et al. Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging. J Nucl Cardiol 2019; 26: 2018-2030
• 32 International Commission on Radiation Protection ICRP. Radiation dose to patients from radiopharmaceuticals – addendum 3 to ICRP publication 53. ICRP publication 106. Ann ICRP 2008; 38: 1-197
• 33 Abbott BG, Case JA, Dorbala S. et al. Contemporary Cardiac SPECT Imaging-Innovations and Best Practices: An Information Statement from the American Society of Nuclear Cardiology. Circ Cardiovasc Imaging 2018; 11: e000020
• 34 Einstein AJ, Blankstein R, Andrews H. et al. Comparison of image quality, myocardial perfusion, and left ventricular function between standard imaging and single-injection ultra-low-dose imaging using a high-efficiency SPECT camera: The MILLISIEVERT study. J Nucl Med 2014; 55: 1430-1437
• 35 Sciagrà R, Lubberink M, Hyafil F. et al. EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging. Eur J Nucl Med Mol Imaging 2021; 48: 1040-1069
• 36 Slart RHJA, Bengel FM, Akincioglu C. et al. Total-Body PET/CT Applications in Cardiovascular Diseases: A Perspective Document of the SNMMI Cardiovascular Council. J Nucl Med 2024; 65: 607-616